CHASKA, Minn.--(BUSINESS WIRE)--LIFECORE BIOMEDICAL, INC. (NASDAQ:LCBM) today reported net sales of $16.6 million in the second quarter ended December 31, 2006, an increase of 9% over net sales of $15.2 million in the second quarter of fiscal year 2006. Foreign currency translation comparisons increased current quarter sales by $222,000 compared to the second quarter of last fiscal year.
